MicroRNAs and depression

With an estimated life-time prevalence of 15 to 17% and an incapacitating illness in 50% of cases, depressive spectrum disorders represent a heavy public health burden. Despite considerable efforts to underpin the molecular and cellular changes associated with depressive states, a global understandi...

Full description

Bibliographic Details
Published in:Neurobiology of Disease
Main Authors: Sophie Mouillet-Richard, Anne Baudry, Jean-Marie Launay, Odile Kellermann
Format: Article
Language:English
Published: Elsevier 2012-05-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996111004104